Virtual Screening Studies to Design Potent CDK2-Cyclin A Inhibitors. - S. Vadivelan; Barij N. Sinha; Sheeba Jem Irudayam; Sarma A. R. P. Jagarlapudi (J. Chem. Inf. Model., 2007)

Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffolds. - Christopher Southan; Kiran Boppana; Sarma A. R. P. Jagarlapudi; Sorel Muresan (J. Cheminformatics, 2011)

Identification, synthesis and evaluation of CSF1R inhibitors using fragment based drug design. - Pavan Kumar Machiraju; Poornachandra Yedla; Satya Prakash Gubbala; Taher Bohari; Jaleel K. V. Abdul; Shili Xu; Rahul Patel; Venkata Ramana Reddy Chittireddy; Kiran Boppana; Sarma A. R. P. Jagarlapudi; Nouri Neamati; Riyaz Syed; et al. (Comput. Biol. Chem., 2019)